Richard /ca/ Murray, CEO and President at Jounce Therapeutics, Inc. (JNCE), sold 132,964 shares at $12.04 ($1.3M) on 2021-01-20, disclosed to the SEC on 2021-01-20.
Open-market sale of $1.3M JNCE by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.54 | 30,000 | $256K | 19.8% |
| 2 | $8.54 | 30,000 | $256K | 19.8% |
| 3 | $9.59 | 40,000 | $384K | 29.7% |
| 4 | $12.04 | 16,482 | $198K | 15.3% |
| 5 | $12.04 | 16,482 | $198K | 15.3% |
| Total | $9.72 avg | 132,964 |
| $1.3M |
| 100% |
| Filing → |
| JNCE | SELL | 2022-01-11 | $416K | — | Filing → |
| JNCE | SELL | 2021-01-25 | $808K | — | Filing → |
| JNCE | SELL | 2021-01-11 | $220K | — | Filing → |